The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Radiomic profiles via machine learning to predict response, overall survival, and KRAS status in metastatic colorectal tumors treated with FOLFOX/bevacizumab/hydroxychloroquine.
 
Saima Rathore
No Relationships to Disclose
 
Mark H. O'Hara
Consulting or Advisory Role - Exelixis; Karyopharm Therapeutics
Research Funding - Bristol-Myers Squibb; Celldex; Lilly; Parker Institute for Cancer Immunotherapy
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
 
Thomas Benjamin Karasic
Research Funding - Celgene; H3 Biomedicine; Syndax; Taiho Pharmaceutical
 
Maryann Redlinger
No Relationships to Disclose
 
Mark Alan Rosen
No Relationships to Disclose
 
Christos Davatzikos
No Relationships to Disclose
 
Peter O'Dwyer
Research Funding - Array BioPharma; Bristol-Myers Squibb; Celgene; Five Prime Therapeutics; Forty Seven; GlaxoSmithKline; H3 Biomedicine; Pharmacyclics; Roche; Taiho Pharmaceutical